ArticleEuropean radiology2019
Does vessel length impact transluminal attenuation gradient in 320-slice coronary CT angiography? Correlation with invasive angiography.
Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Assessment of coronary spasms with transluminal attenuation gradient in coronary computed tomography angiography.PloS one · 2022Article
- Added Value of Transluminal Attenuation Gradient to Qualitative CCTA Ischemia Detection as Determined byDiagnostics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
Abstract
objectivesThis study aimed to investigate the influence of vessel length on transluminal attenuation gradient (TAG) and establish a new index, VLN-TAG (VLN-TAG (HU/100 mm
methodsA total of 150 coronary arteries from 52 patients who underwent single-beat scanning using 320-slice CT and invasive coronary angiography (ICA) within 2 weeks were retrospectively enrolled. TAG was obtained from the major three epicardial vessels, and its interrelation with the measured length of the vessels was evaluated by Pearson correlation and regression analyses. The changes in TAG and VLN-TAG were compared with the corresponding stenosis severities ascertained by ICA using repeated measures ANOVA.
resultsTAG had a significant interrelation with the measured length of the vessels (r = 0.644, p < 0.001). Neither TAG nor VLN-TAG with different stenosis degrees of < 50, 50-70, and 70-99% on ICA had significant difference among the three groups. Plaque composition had no influence on VLN-TAG in all groups. The combined TAG or VLN-TAG and coronary computed tomography angiography (CCTA) assessment did not significantly change the area under the curve compared with using CCTA only. In the calcified vessels group, adding VLN-TAG to CCTA improved the specificity (92.86 vs 85.71%).
conclusionsVessel length is an important factor impacting TAG. TAG does not offer an incremental diagnostic value compared with CCTA only for detecting coronary stenosis. KEY POINTS: • Transluminal attenuation gradient (TAG) does not improve the diagnostic value of CCTA. Vessel length impacts TAG, but VLN-TAG does not improve the diagnostic value of CCTA. • Plaque composition had no influence on VLN-TAG in all groups of stenosis degrees. There may be a minimal improvement in specificity when VLN-TAG is applied to the calcified vessels group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.